A comparison of quality life in children with cerebral palsy and neuromuscular diseases

Öz

Anahtar Kelimeler

• -

Serebral palsi ve nöromusküler hastalığı olan çocuklarda yaşam kalitesinin karşılaştırılması

Öz

Amaç: Bu çalışma, nöromusküler hastalığı (NMH) olan çocuklar ile serebral palsili (SP) çocukların sağlıkla ilişkili yaşam kalitelerini (HRQoL) karşılaştırmak amacıyla planlandı. Gereç ve yöntem: Yaşları 5-18 yaş arasında değişen, 61 serebral palsili çocuk ve 50 NMH’li olan çocuk çalışmaya alındı. Olguların özellikleri kaydedildi. Yaşam kalitesi Çocuk Sağlık Anketi Aile Formu 50 (CHQPF50) kullanılarak değerlendirildi. Çocukların fonksiyonel seviyeleri Barthel İndeksi ile değerlendirildi. Sonuçlar: Gruplar arasında, CHQ-PF50’nin alt skalaları olan genel sağlık algılaması, ailesel etki-emosyonel ve ailesel etki-zaman skorlarında anlamlı fark bulundu (p

Anahtar Kelimeler

• Nöromusküler hastalıklar, Serebral palsi, Yaşam kalitesi, Özürün değerlendirilmesi, Çocuk

Kaynakça

1. Pharoah PO, Cooke T, Rosenbloom I, et al. Trends in birth prevalence of cerebral palsy. Arch Dis Child. 1987; 62: 379-384.
2. Boyle CA, Yeargin-Allsopp M, Doernberg NS, et al. Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program 199l. MMWR CDC Surveill Summ. 1996;45:1-14.
3. Dubowitz W. The Muscular Dystrophies. In: Muscle Disorders in Childhood. Second Edition. WB Saunders Company. London; 1994:34-134.
4. Drougia A, Giapros V, Krallis N, et al. Incidence and risk factors for cerebral palsy in infants with perinatal problems: a 15-year review. Early Hum. Dev. 2007; 83: 541-547.
5. Tangsrud SE, Halvorsen S. Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to non- Duchenne muscular dystrophy. Clin Genet. 1988;34:145-152.
6. Ahlström G, Gunnarsson LG, Leissner P, et al. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology. 1993;12:262-269.
7. Merlini L, Stagni SB, Marri E, et al. Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province, Italy. Neuromuscul Disord. 1992;2:197-200.
8. Serdaroğlu A, Cansu A, Ozkan S, et al. Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol. 2006;48:413- 416.

9. Tunca O, Karaduman A, Aras O. Nöromusküler hastalıklarda fizyoterapi rehabilitasyonun aile ve çocuk üzerindeki etkileri. Fizyoter Rehabil. 1996;8:7-12.
10. Livingston MH, Rosenbaum PL, Russell DJ, et al. Quality of life among adolescents with cerebral palsy: what does the, literature tell us? Dev Med Child Neurol. 2007;49:225-231.
11. Piccininni M, Falsini C, Pizzi A. Quality of life in hereditary neuromuscular diseases. Acta Neurol Scand. 2004;109:113-119.
12. Uchikawa K, Liu M, Hanayama K, et al. Fuctional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med. 2004;36:124-129.
13. Colver A. SPARCLE group. Study protocol: SPARCLE- a multi-centre European study of the relationship of environment to participation and quality of life in children with cerebral palsy. BMC Public Health. 2006;6:105.
14. WHOQOL Assesment Group. Development and general psychometric properties. Soc Sci Med. 1998;46:1569-1855.
15. World Health Organization. Preamble to the Constitution of the World Health Organization. International Health Conference. New York, 19-22 June, 1946. (Official Records of the World Health Organization,no2,p100) http://www.who.int/about/definition/en/print.html, 2003.
16. Landgraft JM, Abetz L, Ware JE. In The CHQ User's Manual. Boston: The Health Institute, New England Medical Center; 1996.
17. Ozdogan H, Ruperto N, Kasapçopur O, et al. The Turkish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001; 19(4 Suppl 23):158-162.
18. Küçükdeveci AA, Yavuzer G, Tennant BA, et al. Adaptation of the modified Barthel index for use in physical medicine and rehabilitation in Turkey. Scand J Rehabil Med. 2000;32:87-92.
19. Raina P, O'Donnell, Rosenbaum P, et al. The health and well-being of caregivers of children with cerebral palsy. Pediatrics. 2005;115:e626-636.
20. Nereo NE, Fee RJ, Hinton VJ. Parental stress in mothers of boys with duchenne muscular dystrophy. J Pediatr Psychol. 2003;28:473-484.
21. Natterlund B, Ahlstrom G. Activities of daily living and quality of life in persons with muscular dystrophy. J Rehabil Med. 2001;33:206-211.
22. Hinton VJ, Fee RJ, Goldstein EM, et al. Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol. 2007;49:123-128.
23. Dickinson H, Parkinson K, McManus V, et al. Assessment of data quality in a multi-centre cross- sectional study of participation and quality of life of children with cerebral palsy. BMC Public Health. 2006;6: 273.
24. Rosenbaum PL, Livingston MH, Palisano RJ, et al. Quality of life and health-related quality of life of adolescents with cerebral palsy. Dev Med Child Neurol. 2007;49:516-521.
25. Schneider JW, Gurucharri LM, Gutierrez AL, et al. Health related quality of life and functional outcome measures for children with cerebral palsy. Dev Med Child Neurol. 2001;43:601-608.
26. Wake M, Salmon L, Reddihough D. Health status of Australian children with mild to severe cerebral palsy: cross-sectional survey using the Child Health Questionnaire. Dev Med Child Neurol. 2003;45:194- 199.
27. Bakker JP, De Groot IJ, Beelen A, et al. Predictive factors of cessation of ambulation in patients with Duchenne Muscular Dystrophy. Am J Phys Med 10 Rehabil. 2002;8l:906-912.
28. Wiley R, Renk K. Psychological correlates of quality of life in children with cerebral palsy. J Dev Phys Disabil. 2007;19:427-447.
29. Curran AL, Sharples PM, White C, et al. Time costs of caring for children with severe disabilities compared with caring for children without disabilities. Dev Med Child Neurol. 2001;43:529- 533.